Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Edesa Biotech Inc (NQ: EDSA )

4.369 -0.041 (-0.93%)
Streaming Delayed Price Updated: 3:48 PM EDT, Sep 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,026
Open 4.410
Bid (Size) 4.210 (1)
Ask (Size) 4.600 (19)
Prev. Close 4.410
Today's Range 4.210 - 4.410
52wk Range 2.460 - 8.333
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EDSA Stock Earnings: Edesa Biotech Beats EPS for Q3 2024
EDSA stock results show that Edesa Biotech beat analyst estimates for earnings per share the third quarter of 2024. 
Via InvestorPlace
BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS
Via ACCESSWIRE

Performance

YTD
-6.65%
-6.65%
1 Month
+1.13%
+1.13%
3 Month
+0.32%
+0.32%
6 Month
+1.60%
+1.60%
1 Year
-30.65%
-30.65%

More News

Read More
EDSA Stock Earnings: Edesa Biotech Beats EPS for Q2 2024
Via InvestorPlace
Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
Via ACCESSWIRE
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
Via ACCESSWIRE
Edesa Biotech to Participate in Upcoming Investor Conferences
Via ACCESSWIRE
Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference
Via ACCESSWIRE
Edesa Biotech to Participate in Barclays Global Healthcare Conference
Via ACCESSWIRE
Edesa Biotech to Participate in Upcoming Dermatology Meetings
Via ACCESSWIRE
Edesa Biotech Reports Fiscal 1st Quarter 2024 Results
Via ACCESSWIRE
Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week
Via ACCESSWIRE
EDSA Stock Earnings: Edesa Biotech Beats EPS for Q4 2023
Via InvestorPlace
Edesa Biotech Reports Fiscal Year 2023 Results
Via ACCESSWIRE
Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Exposures Product Safety
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study
Via ACCESSWIRE
Edesa Biotech to Present at Dermatology Drug Development Summit
Via ACCESSWIRE
Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech’s ARDS Drug
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Via Benzinga
Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Is Infectious Disease Player Edesa Biotech Stock Soaring Today?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.